"NIH-funded scientists are perennially expected to do more with less," writes one stakeholder. Another observer writes, "The current research funding system is due for reform, albeit in a more ...

AMETEK (NYSE:AME – Get Free Report) was upgraded by StockNews.com from a “hold” rating to a “buy” rating in a research report issued to clients and investors on Thursday. Several other brokerages also ...

StockNews.com upgraded shares of Becton, Dickinson and Company (NYSE:BDX – Free Report) from a hold rating to a buy rating in a research note released on Wednesday morning. Separately, Piper Sandler ...

Biomedical research in the U.S. is world-class in part because of a long-standing partnership between universities and the ...

The stock value and growth potential of a biotech firm depend on the type of diseases it treats. This might also include the research that the firm does as it supports other companies, diseases or ...

Know Labs, Inc. (previously NYSE American: KNW, now OTC Markets: KNWN), a pioneering leader in the development and application of radio frequency dielectric spectroscopy (RFDS) for non-invasive ...

Elite Pharmaceuticals, with a market capitalization of $531 million, reported a decline in third-quarter revenue for 2024, falling 8% from the previous year. Despite a strong nine-month performance, ...

OpenAI’s board of directors has formally rejected an offer from a group of investors led by Elon Musk to buy the nonprofit for $97.4 billion. Scarlet Fu reports on “Bloomberg The Close.” ...